Cargando…
N-Acetylcysteine Attenuates the Development of Renal Fibrosis in Transgenic Mice with Dilated Cardiomyopathy
Mechanisms underlying the renal pathology in cardiorenal syndrome (CRS) type 2 remain elusive. We hypothesised that renal glutathione deficiency is central to the development of CRS type 2. Glutathione precursor, N-acetylcysteine (NAC;40 mg/kg/day; 8 weeks) or saline were administered to transgenic...
Autores principales: | Giam, Beverly, Kuruppu, Sanjaya, Chu, Po-Yin, Smith, A. Ian, Marques, Francine Z., Fiedler, April, Horlock, Duncan, Kiriazis, Helen, Du, Xiao-Jun, Kaye, David M., Rajapakse, Niwanthi W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5735149/ https://www.ncbi.nlm.nih.gov/pubmed/29255249 http://dx.doi.org/10.1038/s41598-017-17927-5 |
Ejemplares similares
-
N‐acetylcysteine attenuates the development of cardiac fibrosis and remodeling in a mouse model of heart failure
por: Giam, Beverly, et al.
Publicado: (2016) -
CXCR4 Antagonism Reduces Cardiac Fibrosis and Improves Cardiac Performance in Dilated Cardiomyopathy
por: Chu, Po-Yin, et al.
Publicado: (2019) -
Effects of Dietary l-Arginine on Nitric Oxide Bioavailability in Obese Normotensive and Obese Hypertensive Subjects
por: Giam, Beverly, et al.
Publicado: (2016) -
Stimulation of Angiotensin Converting Enzyme 2: A Novel Treatment Strategy for Diabetic Nephropathy
por: Nomura, Haru, et al.
Publicado: (2022) -
Pharmacological hypothesis: Nitric oxide‐induced inhibition of ADAM‐17 activity as well as vesicle release can in turn prevent the production of soluble endothelin‐converting enzyme
por: Kuruppu, Sanjaya, et al.
Publicado: (2017)